Bayer AG (BAYRY) — Financial statements
Income statement, balance sheet, and cash flow for Bayer AG — annual and quarterly history with growth and margin analysis.
| Metric (EUR Millions) | 2025 | |
|---|---|---|
| Revenue & Gross Profit | ||
| Revenue | 43,776 | |
| Cost of Revenue | 17,858 | |
| Gross Profit | 25,918 | |
| Operating Expenses | ||
| R&D Expenses | 5,541 | |
| General & Administrative Expenses | 0.00 | |
| Selling & Marketing Expenses | 0.00 | |
| SG&A Expenses | 13,707 | |
| Other Expenses | -10 | |
| Operating Expenses | 19,239 | |
| Total Costs & Expenses | 37,097 | |
| Operating Results | ||
| Operating Income | 6,680 | |
| Depreciation & Amortization | 3,895 | |
| EBITDA | 10,575 | |
| EBIT | 6,680 | |
| Interest & Other Income | ||
| Net Interest Income | -1,374 | |
| Interest Income | 280 | |
| Interest Expense | 1,654 | |
| Non-Operating Income | 0.00 | |
| Other Income / Expenses | -9,685 | |
| Income Before Tax | -3,006 | |
| Income Tax Expense | 448 | |
| Net Income & EPS | ||
| Net Income from Continuing Operations | -3,453 | |
| Net Income from Discontinued Operations | 0.00 | |
| Net Income | -3,477 | |
| Bottom-Line Net Income | -3,477 | |
| EPS (Basic) | -0.88 | |
| EPS (Diluted) | -0.88 | |
| Weighted Average Shares | 3,930 | |
| Weighted Average Diluted Shares | 3,930 | |
* All figures in Millions of EUR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.